RICHMOND - Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) announced that it will report its fourth quarter and full-year 2025 financial results on Thursday, February 26, 2026, at 7:00 a.m. U.S. EST.
Following the release of the financial results, Joe Ciaffoni, Chief Executive Officer, and other members of Indivior's leadership team will host a presentation via live webcast at 8:00 a.m. U.S. EST.
Access to the Live Webcast Presentation: The webcast event and materials can be accessed on the 'Investors' section of the company's website at www.indivior.com before the event begins.
Live webcast link: https://edge.media-server.com/mmc/p/f78ufsat
Participants may access the presentation telephonically by registering with the following link: https://register-conf.media-server.com/register/BI44fe43e28e334eb58b41edf49f6f80ce
A replay of the presentation will be available at www.indivior.com.
About Indivior
As the leader in long-acting injectable treatments for opioid use disorder (OUD), Indivior is singularly focused on delivering evidence-based treatment and advancing understanding of OUD as a chronic but treatable brain disease. For more than 25 years, we have revolutionized the science of addiction medicine - developing treatments that help people move toward long-term recovery with independence and dignity. Building on this heritage, we are ushering in a new era, renewing our commitment to individuals living with OUD and carrying forward what matters most: compassion, integrity, and science. Together with science, people living with OUD, public health champions, and communities, we are powering recovery and renewing hope.
Contact:
Jason Thompson
Tel: 804-402-7123
Email: jason.thompson@indivior.com
Cassie France-Kelly
Tel: 804-594-0836
Email: Indiviormediacontacts@indivior.com
(C) 2026 Electronic News Publishing, source ENP Newswire